Pim-1 ligand-bound structures reveal the mechanism of serine/threonine kinase inhibition by LY294002

被引:167
作者
Jacobs, MD [1 ]
Black, J [1 ]
Futer, O [1 ]
Swenson, L [1 ]
Hare, B [1 ]
Fleming, M [1 ]
Saxena, K [1 ]
机构
[1] Vertex Pharmaceut Inc, Cambridge, MA 02139 USA
关键词
D O I
10.1074/jbc.M413155200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Pim-1 is an oncogene-encoded serine/threonine kinase primarily expressed in hematopoietic and germ cell lines. Pim-1 kinase was originally identified in Maloney murine leukemia virus-induced T-cell lymphomas and is associated with multiple cellular functions such as proliferation, survival, differentiation, apoptosis, and tumorigenesis (Wang, Z., Bhattacharya, N., Weaver, M., Petersen, K., Meyer, M., Gapter, L., and Magnuson, N. S. ( 2001) J. Vet. Sci. 2, 167-179). The crystal structures of Pim-1 complexed with staurosporine and adenosine were determined. Although a typical two-domain serine/threonine protein kinase fold is observed, the inter-domain hinge region is unusual in both sequence and conformation; a two-residue insertion causes the hinge to bulge away from the ATP-binding pocket, and a proline residue in the hinge removes a conserved main chain hydrogen bond donor. Without this hydrogen bond, van der Waals interactions with the hinge serve to position the ligand. The hinge region of Pim-1 resembles that of phosphatidylinositol 3-kinase more closely than it does other protein kinases. Although the phosphatidylinositol 3-kinase inhibitor LY294002 also inhibits Pim-1, the structure of the LY294002.Pim-1 complex reveals a new binding mode that may be general for Ser/Thr kinases.
引用
收藏
页码:13728 / 13734
页数:7
相关论文
共 60 条
  • [1] THE HUMAN PROTOONCOGENE PRODUCT P33PIM IS EXPRESSED DURING FETAL HEMATOPOIESIS AND IN DIVERSE LEUKEMIAS
    AMSON, R
    SIGAUX, F
    PRZEDBORSKI, S
    FLANDRIN, G
    GIVOL, D
    TELERMAN, A
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (22) : 8857 - 8861
  • [2] THE CCP4 SUITE - PROGRAMS FOR PROTEIN CRYSTALLOGRAPHY
    BAILEY, S
    [J]. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1994, 50 : 760 - 763
  • [3] The structure of phosphorylated GSK-3β complexed with a peptide, FRATtide, that inhibits β-catenin phosphorylation
    Bax, B
    Carter, PS
    Lewis, C
    Guy, AR
    Bridges, A
    Tanner, R
    Pettman, G
    Mannix, C
    Culbert, AA
    Brown, MJB
    Smith, DG
    Reith, AD
    [J]. STRUCTURE, 2001, 9 (12) : 1143 - 1152
  • [4] BERG MM, 1992, J BIOL CHEM, V267, P13
  • [5] Pim-1 associates with protein complexes necessary for mitosis
    Bhattacharya, N
    Wang, ZP
    Davitt, C
    McKenzie, IFC
    Xing, PX
    Magnuson, NS
    [J]. CHROMOSOMA, 2002, 111 (02) : 80 - 95
  • [6] High-throughput screening for soluble recombinant expressed kinases in Escherichia coli and insect cells
    Chambers, SP
    Austen, DA
    Fulghum, JR
    Kim, WM
    [J]. PROTEIN EXPRESSION AND PURIFICATION, 2004, 36 (01) : 40 - 47
  • [7] Protein kinases - the major drug targets of the twenty-first century?
    Cohen, P
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (04) : 309 - 315
  • [8] Specificity and mechanism of action of some commonly used protein kinase inhibitors
    Davies, SP
    Reddy, H
    Caivano, M
    Cohen, P
    [J]. BIOCHEMICAL JOURNAL, 2000, 351 (351) : 95 - 105
  • [9] CRYSTAL-STRUCTURE OF CYCLIN-DEPENDENT KINASE-2
    DEBONDT, HL
    ROSENBLATT, J
    JANCARIK, J
    JONES, HD
    MORGAN, DO
    KIM, SH
    [J]. NATURE, 1993, 363 (6430) : 595 - 602
  • [10] DeLano W., PYMOL MOL GRAPHICS S